Can someone actually clarify properlyViraxClear has signed a non-binding LOI with Biosonda Biotecnologia (“Biosonda”) for the distribution of up to 3 million Test Kits for the Chilean market, a contract valued at up to $17.25 million in gross revenue.
- On july 7th
But September 4th we signed for 1 million test and we have received 3.5 million dollars
- Does that mean we have another 2.75 million coming as the 3.5 mill was just a deposit.
Quick maths -17.25 mil divide by 3 mil = 5.75 $ Million for 1 mil devices. so im just confused, wish they would clarify the NR better and actually state how much gross and net profit will be.
It was supposed to be a 3 million tests LOI and they said guatemala and others to follow.. how soon?